Tubulin-binding dibenz[c,e]oxepines: Part 2. Structural variation and biological evaluation as tumour vasculature disrupting agents

Research output: Contribution to journalArticlepeer-review


5,7-Dihydro-3,9,10,11-tetramethoxybenz[c,e]oxepin-4-ol 1, prepared from a dibenzyl ether precursor via Pd-catalysed intramolecular direct arylation, possesses broad-spectrum in vitro cytotoxicity towards various tumour cell lines, and induces vascular shutdown, necrosis and growth delay in tumour xenografts in mice at sub-toxic doses. The biological properties of 1 and related compounds can be attributed to their ability to inhibit microtubule assembly at the micromolar level, by binding reversibly to the same site of the tubulin αβ-heterodimer as colchicine 2 and the allocolchinol, N-acetylcolchinol 4.

Bibliographical metadata

Original languageEnglish
Pages (from-to)1630-1642
Number of pages13
JournalBioorganic and Medicinal Chemistry
Issue number5
Early online date19 Jan 2017
Publication statusPublished - 1 Mar 2017

Related information


Research output: Contribution to journalArticlepeer-review

View all (1)


View all